ICMR and Panacea Biotec initiates Phase III clinical trial of DengiAll
The clinical trial will be conducted at 19 sites with 10,335 participants across India
The clinical trial will be conducted at 19 sites with 10,335 participants across India
The partnership marks a significant milestone in integrating digital health education into medical curricula
Morepen Labs successfully raised Rs. 200 Crore through QIP
Q1FY25 Revenue from Operations grew by 15% to Rs. 177 crore
The comprehensive criteria encompasses evaluation of debt management, sales growth, earnings-per-share performance, as well as returns on equity
Our centers are performing as expected or even better
Trazodone tablets are indicated for the treatment of major depressive disorder in adults
Revenue from Operations increased by 10.5% YoY to Rs. 7,567 crore with growth across the businesses
The drugmaker's net profit slipped 26 per cent on-year to Rs 143.8 crore
Observes no adverse impact of non-nutritive sweetener (NNS) - sucralose on glycemic markers
Subscribe To Our Newsletter & Stay Updated